The Program shall review prescription monitoring data and naloxone medication data for indications of possible: Misuse or abuse of a monitored prescription drug; and Violations of law or possible breaches of professional standards by a prescriber or a dispenser. In determining whether its review indicates a possible violation of law or possible breach of professional standards by a prescriber or dispenser, the Program shall take into account to the extent practicable the particular specialty, circumstances, patient type, and location of the prescriber or dispenser.